Cargando…

A Comment on Boyers et al.: “Eltrombopag for the Treatment of Chronic Immune or Idiopathic Thrombocytopenic Purpura: A NICE Single Technology Appraisal”

Detalles Bibliográficos
Autores principales: Allen, Rachel, Brainsky, Andres, Grotzinger, Kelly, Roccia, Tito
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing AG 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3693436/
https://www.ncbi.nlm.nih.gov/pubmed/23329595
http://dx.doi.org/10.1007/s40273-012-0003-8
_version_ 1782274726520946688
author Allen, Rachel
Brainsky, Andres
Grotzinger, Kelly
Roccia, Tito
author_facet Allen, Rachel
Brainsky, Andres
Grotzinger, Kelly
Roccia, Tito
author_sort Allen, Rachel
collection PubMed
description
format Online
Article
Text
id pubmed-3693436
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Springer International Publishing AG
record_format MEDLINE/PubMed
spelling pubmed-36934362013-07-15 A Comment on Boyers et al.: “Eltrombopag for the Treatment of Chronic Immune or Idiopathic Thrombocytopenic Purpura: A NICE Single Technology Appraisal” Allen, Rachel Brainsky, Andres Grotzinger, Kelly Roccia, Tito Pharmacoeconomics Correspondence Springer International Publishing AG 2012-11-23 2013 /pmc/articles/PMC3693436/ /pubmed/23329595 http://dx.doi.org/10.1007/s40273-012-0003-8 Text en © The Author(s) 2012 https://creativecommons.org/licenses/by-nc/2.5/ Open AccessThis article is distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited.
spellingShingle Correspondence
Allen, Rachel
Brainsky, Andres
Grotzinger, Kelly
Roccia, Tito
A Comment on Boyers et al.: “Eltrombopag for the Treatment of Chronic Immune or Idiopathic Thrombocytopenic Purpura: A NICE Single Technology Appraisal”
title A Comment on Boyers et al.: “Eltrombopag for the Treatment of Chronic Immune or Idiopathic Thrombocytopenic Purpura: A NICE Single Technology Appraisal”
title_full A Comment on Boyers et al.: “Eltrombopag for the Treatment of Chronic Immune or Idiopathic Thrombocytopenic Purpura: A NICE Single Technology Appraisal”
title_fullStr A Comment on Boyers et al.: “Eltrombopag for the Treatment of Chronic Immune or Idiopathic Thrombocytopenic Purpura: A NICE Single Technology Appraisal”
title_full_unstemmed A Comment on Boyers et al.: “Eltrombopag for the Treatment of Chronic Immune or Idiopathic Thrombocytopenic Purpura: A NICE Single Technology Appraisal”
title_short A Comment on Boyers et al.: “Eltrombopag for the Treatment of Chronic Immune or Idiopathic Thrombocytopenic Purpura: A NICE Single Technology Appraisal”
title_sort comment on boyers et al.: “eltrombopag for the treatment of chronic immune or idiopathic thrombocytopenic purpura: a nice single technology appraisal”
topic Correspondence
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3693436/
https://www.ncbi.nlm.nih.gov/pubmed/23329595
http://dx.doi.org/10.1007/s40273-012-0003-8
work_keys_str_mv AT allenrachel acommentonboyersetaleltrombopagforthetreatmentofchronicimmuneoridiopathicthrombocytopenicpurpuraanicesingletechnologyappraisal
AT brainskyandres acommentonboyersetaleltrombopagforthetreatmentofchronicimmuneoridiopathicthrombocytopenicpurpuraanicesingletechnologyappraisal
AT grotzingerkelly acommentonboyersetaleltrombopagforthetreatmentofchronicimmuneoridiopathicthrombocytopenicpurpuraanicesingletechnologyappraisal
AT rocciatito acommentonboyersetaleltrombopagforthetreatmentofchronicimmuneoridiopathicthrombocytopenicpurpuraanicesingletechnologyappraisal
AT allenrachel commentonboyersetaleltrombopagforthetreatmentofchronicimmuneoridiopathicthrombocytopenicpurpuraanicesingletechnologyappraisal
AT brainskyandres commentonboyersetaleltrombopagforthetreatmentofchronicimmuneoridiopathicthrombocytopenicpurpuraanicesingletechnologyappraisal
AT grotzingerkelly commentonboyersetaleltrombopagforthetreatmentofchronicimmuneoridiopathicthrombocytopenicpurpuraanicesingletechnologyappraisal
AT rocciatito commentonboyersetaleltrombopagforthetreatmentofchronicimmuneoridiopathicthrombocytopenicpurpuraanicesingletechnologyappraisal